Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: TEVA PHARMACEUTICALS USA, INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-01-18 to 2022-01-25
Current total value of award: $587295.72
Description: 8508811981!ADENOVIRUS TYPE 4 A